Insider buying last 90 days
No open-market insider purchases were filed for JBS in the last 90 days.
From Form 4 filings, dated to when each was filed.
JBS drew attention this week from analysts flagging a likely decline in earnings ahead of its upcoming report, noting the company may lack the combination of factors typically associated with an earnings beat.
The stock closed at $12.96, up 6.2% on the day, sitting between its 50-day average of $12.44 and its 200-day average of $14.07. The GekkoIndex reads 54.5, placing JBS in the Neutral zone, down from a five-day change of -11.5. Price remains 36.5% below the Gekko Fair Value of $20.42.
JBS reports next on 9 November 2026, four days away and within a typical 20-trading-day holding window. Its last report missed estimates, with EPS of $0.20 against expectations of $0.31, and shares reacted -8.5% at the time, compared with an average absolute reaction of 4.1% over recent quarters. The company has beaten estimates in 5 of its last 8 quarters. No insider, Congress, or unusual options activity appears in their respective windows, though one billionaire holder is recorded. Among the 8 covering firms, all 8 rate the stock a buy, with a consensus target of $17.16, implying a 32.4% upside from current levels.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
JBS scores 1 supportive, 2 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed1 headwind
Averages disagree
Close $12.96 sits between the 50-day ($12.44) and 200-day ($14.07) averages, or the averages disagree.
See the chart54.5, Neutral
Reading 54.5 is in the Neutral zone.
See the GekkoIndex36.5% below
Price is 36.5% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 4 days
Reports on Nov 9, 2026, 4 days away — inside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
JBS closed at $12.96 on Nov 4, 2026, −3.5% over the past year, inside a 52-week range of $10.61 to $18.65.
Use the left and right arrow keys to read daily values.
Put JBS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
JBS produces meat for sale to consumers and businesses, covering beef, pork, lamb and poultry. Its products reach the market through grocery chains, club-style retailers and other retail outlets, as well as through foodservice operators that supply restaurants and similar establishments. The company is recognized for this broad line of meat products spanning multiple animal categories.
Rather than focusing on a single type of meat, JBS sells across several categories to a mix of retail and foodservice buyers, positioning it to serve both everyday grocery shoppers and commercial food operations through its various distribution channels.
JBS traces its founding to October 9, 2019, and its headquarters sit in Amstelveen, the Netherlands. Shares of the company are listed on the NYSE under the ticker JBS.
JBS’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.5, in the Neutral zone, down 11.5 points over five sessions.
Down 11.5 points over five sessions, from the Accumulation zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 37 | +0.1% | +2.5% | ||
| Accumulation | 115 | −0.1% | +3.0% | ||
| Neutral (current zone) | 167 | 0.0% | −2.2% | ||
| Distribution | 24 | −0.2% | −3.0% | ||
| Selling | 0 | Not available | |||
Average JBS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
JBS trades 36.5% below Gekko Fair Value of $20.42, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what JBS shares are worth, recalculated every trading day.
$20.42
Gekko Fair Value, Nov 4, 2026
36.5% Undervalued
At the end of Aug 2026 the price was 17.2% below the estimate.
No open-market insider purchases were filed for JBS, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for JBS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in JBS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
JBS has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds JBS.
JBS reports on Nov 9, 2026 (4 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 9, 2026
4 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 10, 2026 | $0.20 est $0.31 | $23.90B est $23.04B | −8.5% |
| May 12, 2026 | $0.00 est $1.13 | $21.61B est $21.66B | −5.8% |
| Feb 11, 2026 | $3.07 est $2.25 | $23.06B est $119.5B | −2.0% |
| Nov 13, 2025 | $0.52 est $0.51 | $22.60B est $21.96B | +0.8% |
| Aug 13, 2025 | $0.53 est $0.51 | $21.90B est $21.96B | −3.4% |
| May 13, 2025 | $0.50 est $0.23 | $20.45B est $19.37B | — |
| Mar 25, 2025 | $0.19 est $0.28 | $20.55B est $20.02B | — |
| Nov 13, 2024 | $0.30 est $0.30 | $19.14B est $19.14B | — |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for JBS is $17.16, +32.4% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 28 | Bank of America Securities | — | — |
| Oct 22 | J.P. Morgan | $17.50 | +35.0% |
| Oct 21 | Goldman Sachs | $17 | +31.2% |
| Oct 14 | Barclays | $20 | +54.3% |
| Oct 9 | J.P. Morgan | $18 | +38.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
JBS’s market cap is $28.75B, with a P/E ratio of 11.6 and revenue of $91.17B over the last twelve months.
1 headline about JBS from the past week, newest first, each linking to the publisher.
JBS’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TSNTyson Foods | Distribution | 16.6% below |
| HRLHormel Foods | Distribution | 11.3% below |
| MICCMagnum Ice Cream | Neutral | 30.2% below |
| SFDSmithfield Foods | Neutral | 40.8% below |
| MAMAMama's Creations | Neutral | 12.7% below |
| LWAYLifeway Foods | Accumulation | 31.4% below |
A peer links to its own page where one exists.
JBS’s market cap is $28.75B at the Nov 4, 2026 close of $12.96, with 776.1M shares outstanding. The shares trade on a P/E ratio of 11.6.
The consensus analyst 12-month price target for JBS is $17.16, +32.4% from the last close. Of the 8 firms that rated the stock in the last 90 days, 8 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate JBS is undervalued: the Nov 4, 2026 close of $12.96 is 36.5% below Gekko Fair Value of $20.42. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
JBS is expected to report on Nov 9, 2026 (4 days away). Analysts expect earnings of $0.22 per share on revenue of $22.89B. JBS beat the earnings estimate in 5 of its last 8 reports, moving 4.1% on average across the report.
JBS’s 52-week high is $18.65 and its 52-week low is $10.61; it closed at $12.96 on Nov 4, 2026, −3.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 4 items with data read as supportive (fair value), 2 as mixed (trend and gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,460 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.